TaeWooKimMD

Radiology • Chicago, IL

Neuroradiology

Physician

Join to view full profile

Are you Dr. Kim?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 15 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
5145 N California Avenue
Swedish Covenant Hospital
Chicago, IL 60625
Phone+1 773-989-3814

Fax+1 773-989-6230
Is this information wrong?

Summary

Dr. Tae Kim, MD is a board certified radiologist in Chicago, Illinois. He is currently licensed to practice medicine in Illinois.

Education & Training

Rush University Medical CenterFellowship, Neuroradiology, 1991 - 1993
Loyola University Medical CenterResidency, Radiology-Diagnostic, 1976 - 1979
Columbus HospitalInternship, Transitional Year, 1975 - 1976
Kyungpook National University College of MedicineClass of 1972

Certifications & Licensure

IL State Medical License 1978 - 2014
American Board of Radiology Radiology

Clinical Trials

Prospective Cohort Study of Pancreatic Cancer Patients Treated With Proton Beam Therapy Start of enrollment: 2018 Sep 21
Enrolling by invitation

Publications & Presentations

PubMed

Pediatric malignant hyperthermia: risk factors, morbidity, and mortality identified from the Nationwide Inpatient Sample and Kids' Inpatient Database.
Salazar, J. H.,Yang, J.,Shen, L.,Abdullah, F.,Kim, T. W.> ;Paediatr Anaesth. 2014 Jul 01
9 citations
Washout times of desflurane, sevoflurane and isoflurane from the GE Healthcare Aisys® and Avance®, Carestation®, and Aestiva® anesthesia system.
Tae W. Kim, Jamie R. Wingate, Allison M. Fernández, Emmett E. Whitaker, Robert Q Tham> ;Paediatric Anaesthesia. 2013 Dec 1
Chemotherapy Acts as an Adjuvant to Convert the Tumor Microenvironment into a Highly Permissive State for Vaccination-Induced Antitumor Immunity.
Kang, T. H.,Mao, C. P.,Lee, S. Y.,Chen, A.,Lee, J. H.,Kim, T. W.,Alvarez, R. D.,Roden, R. B.,Pardoll, D.,Hung, C. F.,Wu, T. C.> ;Cancer Res.. 2013 Apr 15
The kinase activity of interleukin-1 receptor-associated kinase 2 is essential for lipopolysaccharide-mediated cytokine and chemokine mRNA stability and translation.
Yin, W., Wan, Y., Kim, T.W., Yao, P., Xiao, H., Zhou, H., Xiao, J., Fox, P., Li, X.> ;J Interferon Cytokine Res. 2011 May
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer.
Kim, C., Lee, J., Ryu, M., Chang, H.M., Kim, T.W., Lim, H.Y., Kang, H.J., Park, Y.S., Ryoo, B., Kang, Y.> ;Invest New Drugs. 2011-04-01
A phase I study of S-1 treatment with a 3 week schedule in advanced biliary cancer patients with or without hepatic dysfunction.
Yoon, D.H., Lee, H.J., Hong, Y.S., Kim, K., Lee, S.S., Lee, J., Chang, H.M., Ryu, M., Kang, Y., Lee, J.S., Kim, T.W.> ;Invest New Drugs. 2011 Apr
Spontaneous reactive astrogliosis in the dentate gyrus of Bax-deficient mice.
Kim, T.W., Kim, H., Sun, W.> ;Mol Cells. 2011 Apr
Geraniol inhibits prostate cancer growth by targeting cell cycle and apoptosis pathways.
Kim, S., Bae, H.C., Park, E., Lee, C.R., Kim, B., Lee, S., Park, H.H., Kim, S., So, I., Kim, T.W., Jeon, J.> ;Biochem Biophys Res Commun. 2011 Apr 1
Induction of Per1 expression following an experimentally induced epilepsy in the mouse hippocampus.
Eun, B.,Kim, H. J.,Kim, S. Y.,Kim, T. W.,Hong, S. T.,Choi, K. M.,Shim, J. K.,Moon, Y.,Son, G. H.,Kim, K.,Kim, H.,Sun, W.> ;Neurosci Lett. 2011 Jul 8
Phase I study of preoperative chemoradiation with s-1 and oxaliplatin in patients with locally advanced resectable rectal cancer.
Hong, Y.S., Lee, J., Park, J.H., Kim, J.H., Yoon, S.N., Lim, S., Yu, C.S., Kim, M., Jang, S., Lee, J.S., Kim, J.C., Kim, T.W.> ;Int J Radiat Oncol Biol Phys. 2011 Mar 1
Postoperative chemoradiotherapy for extrahepatic bile duct cancer.
Park, J., Choi, E.K., Ahn, S.D., Lee, S., Song, S.Y., Yoon, S.M., Kim, Y.S., Lee, Y.S., Lee, S., Hwang, S., Lee, Y., Park, K., Kim, T.W., Chang, H.M., Lee, J., Kim, J.H.> ;Int J Radiat Oncol Biol Phys. 2011 Mar 1
Novel chemosensitive single-nucleotide polymorphism markers to targeted regimens in metastatic colorectal cancer.
Kim, J.C., Kim, S.Y., Cho, D.H., Ha, Y.J., Choi, E.Y., Kim, C.W., Roh, S.A., Kim, T.W., Ju, H., Kim, Y.S.> ;Clin Cancer Res. 2011 Mar 1
The dual functions of IL-1 receptor-associated kinase 2 in TLR9-mediated IFN and proinflammatory cytokine production.
Wan, Y., Kim, T.W., Yu, M., Zhou, H., Yamashita, M., Kang, Z., Yin, W., Wang, J., Thomas, J., Sen, G.C., Stark, G.R., Li, X.> ;J Immunol. 2011 Mar 1
37 citations
The Critical Role of IL-1 Receptor-Associated Kinase 4-Mediated NF-κB Activation in Modified Low-Density Lipoprotein-Induced Inflammatory Gene Expression and Atheroscl...
Tae Whan Kim, Maria Febbraio, Peggy Robinet, Brandon DuGar, Diane J. Greene, Anna M. Cerny, Eicke Latz, Raymond Gilmour, Kirk A. Staschke, Guy M. Chisolm, Paul L. Fox,...> ;Journal of Immunology. 2011 Mar 1
Mucinous Rectal Cancer: Effectiveness of Preoperative Chemoradiotherapy and Prognosis.
Shin, U.S., Yu, C.S., Kim, J.H., Kim, T.W., Lim, S., Yoon, S.N., Yoon, Y.S., Kim, C.W., Kim, J.C.> ;Ann Surg Oncol. 2011 Aug
Characteristics and prognosis of patients with colorectal cancer-associated brain metastases in the era of modern systemic chemotherapy.
Baek, J.Y., Kang, M.H., Hong, Y.S., Kim, T.W., Kim, D.Y., Oh, J.H., Lee, S.H., Park, J.H., Kim, J.H., Kim, S.Y.> ;J Neurooncol. 2011 Sep
Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer.
Park, J., Yoon, S.M., Yu, C.S., Kim, J.H., Kim, T.W., Kim, J.C.> ;Cancer. 2011 Aug 15
A phase I study of combination therapy with S-1 and irinotecan in patients with previously untreated metastatic or recurrent colorectal cancer.
Choi, Y.H., Kim, T.W., Lee, S.S., Hong, Y.S., Ryu, M., Lee, J., Chang, H.M., Kang, Y.> ;Cancer Chemother Pharmacol. 2011 Oct
A prognostic model in patients who receive chemotherapy for metastatic or recurrent gastric cancer: validation and comparison with previous models.
Koo, D.H., Ryoo, B., Kim, H.J., Ryu, M., Lee, S., Moon, J., Chang, H., Lee, J., Kim, T.W., Kang, Y.> ;Cancer Chemother Pharmacol. 2011 Oct
Enhancement of DNA vaccine potency by antigen linkage to IFN-Î³-inducible protein-10.
Kang, T.H., Kim, K.W., Bae, H.C., Seong, S., Kim, T.W.> ;Int J Cancer. 2011 Feb 1
Nanoscale two-bit/cell NAND silicon-oxide-nitride-oxide-silicon devices with a separated double-gate saddle-type structure.
Park, S.S., You, J.H., Kwack, K.D., Kim, T.W.> ;J Nanosci Nanotechnol. 2011 Feb
White organic light-emitting devices utilizing a mixed color-conversion phosphor layer consisting of CaAl12O19:Mn and Zn2SiO4:Mn.
Ahn, S.D., Jeong, H.S., Choo, D.C., Kim, T.W., Lee, J.Y., Park, J.H., Kwon, M.S.> ;J Nanosci Nanotechnol. 2011 Feb
Changes in imatinib plasma trough level during long-term treatment of patients with advanced gastrointestinal stromal tumors: correlation between changes in covariates...
Yoo, C., Ryu, M., Ryoo, B., Beck, M.Y., Chang, H., Lee, J., Kim, T.W., Kang, Y.> ;Invest New Drugs. 2012 Aug
Preparation of modern anesthesia workstations for malignant hyperthermia-susceptible patients: a review of past and present practice.
Kim, T.W., Nemergut, M.E.> ;Anesthesiology. 2011 Jan
Charging and discharging mechanisms of organic bistable devices based on ZnO nanoparticles capped with a poly N-vinylcarbazole polymer.
Son, D.I., Oh, D.H., Jung, J.H., Kim, T.W.> ;J Nanosci Nanotechnol. 2011 Jan
Join now to see all